Vericel (VCEL) Research & Development (2010 - 2026)
Vericel (VCEL) reported Research & Development of $8.1 million for Q1 2026, up 11.61% on a YoY basis from $7.3 million in Q1 2025, and up 11.73% sequentially from $7.3 million in Q4 2025.
Vericel (VCEL) Research & Development (2010 - 2026) Analysis & Trends
Vericel (VCEL) has 17 years of Research & Development data on file, last reported at $8.1 million in Q1 2026.
- For the quarter ending Q1 2026, Research & Development rose 11.61% year-over-year to $8.1 million; the trailing twelve-month figure through Mar 2026 stood at $28.4 million (up 10.79% YoY), and the FY2025 full-year result was $27.6 million, up 11.15% from the prior year.
- Research & Development grew to $8.1 million in Q1 2026, from $7.3 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $8.1 million in Q1 2026 to a low of $4.8 million in Q2 2022.
- A 5-year average of $6.0 million and a median of $5.7 million in 2023 frame the typical range for Research & Development.
- Peak annual rise in Research & Development reached 47.33% in 2025, while the deepest fall reached 8.58% in 2025.
- Tracing VCEL's Research & Development over 5 years: stood at $5.2 million in 2022, then dropped by 6.56% to $4.9 million in 2023, then increased by 0.45% to $4.9 million in 2024, then soared by 47.33% to $7.3 million in 2025, then gained by 11.73% to $8.1 million in 2026.
- Business Quant data shows VCEL's Research & Development at $8.1 million in Q1 2026, $7.3 million in Q4 2025, and $6.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 541.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -2.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.37 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 343.97 Mn |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn | 8.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.10 Mn |
| Dec 31, 2025 | 7.25 Mn |
| Sep 30, 2025 | 6.32 Mn |
| Jun 30, 2025 | 6.73 Mn |
| Mar 31, 2025 | 7.26 Mn |
| Dec 31, 2024 | 4.92 Mn |
| Sep 30, 2024 | 6.09 Mn |
| Jun 30, 2024 | 7.36 Mn |
| Mar 31, 2024 | 6.42 Mn |
| Dec 31, 2023 | 4.90 Mn |
| Sep 30, 2023 | 5.68 Mn |
| Jun 30, 2023 | 5.25 Mn |
| Mar 31, 2023 | 5.21 Mn |
| Dec 31, 2022 | 5.25 Mn |
| Sep 30, 2022 | 5.05 Mn |
| Jun 30, 2022 | 4.79 Mn |
| Mar 31, 2022 | 4.86 Mn |
| Dec 31, 2021 | 3.92 Mn |
| Sep 30, 2021 | 4.28 Mn |
| Jun 30, 2021 | 4.45 Mn |